Vycor Medical (VYCO) Gains from Investment Securities (2017 - 2019)
Vycor Medical's (VYCO) quarterly Gains from Investment Securities came in at $749.0 in Q2 2019, up 723.08% year-on-year from $91.0 in Q2 2018, and up 723.08% on a QoQ basis from $91.0 in Q2 2018.
Vycor Medical (VYCO) Gains from Investment Securities (2017 - 2019) Analysis & Trends
Vycor Medical (VYCO) has 3 years of Gains from Investment Securities data on file, last reported at $749.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 749.00 |
| Jun 30, 2019 | 749.00 |
| Jun 30, 2018 | 91.00 |
| Jun 30, 2018 | 91.00 |
| Sep 30, 2017 | -646.00 |
| Sep 30, 2017 | -646.00 |